CAPINTEC CRC 55T SERIES DOSE CALIBRATORS, MODELS CRC 55TR, CRC 55TPET AND CRC 55TW
K101452 · Capintec, Inc. · KPT · Aug 9, 2010 · Radiology
Device Facts
Record ID
K101452
Device Name
CAPINTEC CRC 55T SERIES DOSE CALIBRATORS, MODELS CRC 55TR, CRC 55TPET AND CRC 55TW
Applicant
Capintec, Inc.
Product Code
KPT · Radiology
Decision Date
Aug 9, 2010
Decision
SESE
Submission Type
Special
Regulation
21 CFR 892.1360
Device Class
Class 2
Intended Use
The CRC 55t series, which includes the standard 55tR dose calibrator, reduced pressure chamber (CRC 55tPET) and well counter (CRC55tW), is intended to be used by qualified nuclear medicine technologists, nuclear medicine physicians, and radiopharmacists to measure a wide range of radiopharmaceuticals and radioactive materials, including high energy beta and gamma emitters for diagnostic, therapeutic, or in vitro laboratory tests. It is also designed for use by trained medical physicists to measure the output of most radioactive brachytherapy sources, including LDR, HDR, and IVBT sources. All brachytherapy sources must be measured in the appropriate source holder. The well counter is designed for measurement of low activity radioactive sources or solutions in vitro laboratory test applications. This device is also used in numerous research applications for measurement of radioactive materials.
Device Story
Dose calibrator for measuring radioactive materials; inputs include radioactive samples/sources; utilizes detector technology to measure activity; outputs include activity measurements and spectral identification; operated by nuclear medicine professionals/physicists in clinical/laboratory settings; features color touch screen interface for data input/display; includes 256-channel Multi-Channel Analyzer (MCA) for isotope identification; replaces traditional keypad with touch screen; provides improved visibility, graphic displays, and reporting; assists in verifying radiopharmaceutical doses and brachytherapy source output; enhances safety through improved data management and isotope identification.
Clinical Evidence
Bench testing only. No clinical data provided. Device performance validated against electrical safety and EMC standards including IEC 61010-1, IEC 61010-2-101, IEC 60601-1-2, UL 61010A-1, and CAN/CSA-C22.2 standards.
Technological Characteristics
Radionuclide dose calibrator; utilizes radiation detector technology; features 256-channel Multi-Channel Analyzer (MCA); color touch screen interface; electrical safety compliance per IEC 61010-1, IEC 61010-2-101, IEC 60601-1-2, UL 61010A-1, and CAN/CSA-C22.2 standards.
Indications for Use
Indicated for use by nuclear medicine technologists, physicians, radiopharmacists, and medical physicists to measure radiopharmaceuticals, radioactive materials, and brachytherapy sources (LDR, HDR, IVBT) for diagnostic, therapeutic, and in vitro laboratory applications.
Regulatory Classification
Identification
A radionuclide dose calibrator is a radiation detection device intended to assay radionuclides before their administration to patients.
Predicate Devices
CRC 25 series
Related Devices
K141413 — CRC PC WITH SMART CHAMBER · Capintec, Inc. · Jun 27, 2014
K090296 — ATOMLAB 400 AND ATOMLAB 500 DOSE CALIBRATORS, MODELS 086-330, -331, -332, -335 AND -336 · Biodex Medical Systems, Inc. · Feb 19, 2009
K071396 — CRC 25 SERIES (CRC 25R, CRC 25PET, CRC 25W) DOSE CALIBRATORS · Capintec, Inc. · Jun 28, 2007
K192199 — CRC PC Smart Chamber K1 · Capintec, Inc. · Sep 12, 2019
K052595 — CRC 15ULTRA · Capintec, Inc. · Nov 8, 2005
Submission Summary (Full Text)
{0}------------------------------------------------
AUG - 9 2010
Image /page/0/Picture/1 description: The image shows the logo for CAPINTEC, INC. The logo features the letters "CII" stacked on top of each other inside of a black box. Below the box is the text "CAPINTEC, INC." in a simple, sans-serif font. The logo is black and white.
July 9, 2010
RE: Summary of Safety and Effectiveness Information for the Capintec CRC 55t series.
Capintec's CRC 55t series dose calibrators are designed for measurement of radioactive materials used in nuclear medicine, therapy, laboratory tests, and research applications. The unit is intended for use by trained nuclear medicine technologists, nuclear medicine physicians, radiopharmacists, or medical physicists for diagnostic, in vitro, and therapeutic applications.
The CRC 55t series uses the same principles of operation, same basic electronic circuitry, and same detector technology as the predicated device, CRC 25 series. The basic detection, measurement process, design concepts, functionality, calculations, algorithms, and response remain the same as the predicate device. There are no differences in intended use or effectiveness. The 55t replaces the traditional keypad interface with a larger color touch screen display. The CRC 55t provides enhanced user interface features associated with newer touch screen technology. In addition, the CRC 55t provides an expanded MCA for isotope identification. The predicate device contains 6 fixed channels which provides only preliminary information. The CRC 55t includes a 256 channel MCA which permits spectral identification.
The predicate devices, Capintec dose calibrator lines, upon which the CRC 55t is based, have a long history of over 30 years of safe, reliable, and effective use in the field. The addition of a larger color touch screen interface enhances safety and effectiveness by providing improved visibility, easier alphanumeric data input, better graphic displays. more preset functions, and improved reports. The enhanced MCA provides improved isotope identification. The CRC 55t family of dose calibrators have been tested and approved to the following EMC and electrical safety standards for laboratory equipment:
- IEC 61010-1 Safety requirements for electrical equipment for measurement, . control, and laboratory use-Part 1 General Requirements
- IEC 61010-2-101 Safety requirements for electrical equipment for measurement. . control, and laboratory use-Part 2 Particular Requirement for In Vitro Diagnostic Equipment
- IEC 60601-1-2 Medical electrical equipment Part 1-2: General requirements for . basic safety and essential performance -Collateral standard: Electromagnetic compatibility - Requirements and tests
- UL 61010A-1 Electrical Equipment for Laboratory Use; Part 1: General . Requirements
- CAN/CSA-C22.2 No. 61010-1-04 Standard for Safety Electrical Equipment for . Measurement, Control, and Laboratory Use; Part 1: General Requirements
- CAN/CSA-C22.2 No. 61010-2-101-04 Safety Requirements for Electrical . Equipment for Measurement, Control, and Laboratory Use; Part 2-101: Particular Requirements for In Vitro Diagnostics (IVD) Medical Equipment
620 Alpha Drive • Pittsburgh, PA 15238 U.S.A. • (412) 963-1988 FAX (412) 963-0610
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows a logo for the Department of Health. The logo features a stylized abstract symbol consisting of three curved lines stacked on top of each other. To the left of the symbol, the words "DEPARTMENT OF HEALTH" are arranged vertically in a curved manner.
## DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Ms. Mary Anne Dell Vice President, Manufacturing Capintec, Inc. 620 Alpha Drive PITTSBURG PA 15238
AUG - 9 2010
Re: K101452
Trade/Device Name: CRC 55t Series Regulation Number: 21 CFR 892.1360 Regulation Name: Radionuclide dose calibrator Regulatory Class: II Product Code: KPT and JAQ Dated: July.27, 2010 Received: July 28, 2010
Dear Ms. Dell:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
{2}------------------------------------------------
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 200). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (01) 796-5450: Also, please note the regulation entitled, "Misbranding by reference to parent ket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll the from the (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Sincerely yours,
Donald J. St.Pierre Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
K101452
Appendix # 5
Indications for Use Form
Page _________________________________________________________________________________________________________________________________________________________________________ of of ________________________________________________________________________________________________________________________________________________________________________ ﺍﻟﻤﺴﺎﺣﺔ ﺍﻟﻤﺴﺘﻘﻠﺔ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘ
510(k) Number K 101452
Device Name: CRC 55t series
Indications For Use: The CRC 55t series, which includes the standard 55tR dose calibrator, reduced pressure chamber (CRC 55tPET) and well counter (CRC55tW), is intended to be used by qualified nuclear medicine technologists, nuclear medicine physicians, and radiopharmacists to measure a wide range of radiopharmaceuticals and radioactive materials, including high energy beta and gamma emitters for diagnostic, therapeutic, or in vitro laboratory tests. It is also designed for use by trained medical physicists to measure the output of most radioactive brachytherapy sources, including LDR, HDR, and IVBT sources. All brachytherapy sources must be measured in the appropriate source holder. The well counter is designed for measurement of low activity radioactive sources or solutions in vitro laboratory test applications. This device is also used in numerous research applications for measurement of radioactive materials.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Affice of Device Evaluation (QBE) OTT/ / OR Over-The-Counter Use Prescription Use I (Per 21 CFR 801.109) (Optional Format 1-2-96) Divisio Division of Rac logical Devic
Division of Imaging
Office of In Vitro Diagnostic Device Evaluation and Safety
K161452
510K
AUG - 9 2010
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.